TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Bevacizumab Erlotinib Switch Maintenance in Chemo-Responsive Advanced Gallbladder and Cholangiocarcinoma (BEER BTC): A Multicenter, Open-Label, Randomized, Phase II Trial.

Anant Ramaswamy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.